Please enable JavaScript to continue using this application.

Compare tickers

Valuation, margins, and growth side by side.

Compare $AMRX vs $DFTX | Chartloom

Compare

$AMRX vs $DFTX

Amneal Pharmaceuticals Inc · Definium Therapeutics Inc

AMRX

Amneal Pharmaceuticals Inc

DFTX

Definium Therapeutics Inc

Compare $AMRX vs $DFTX

Comparing Amneal Pharmaceuticals Inc and Definium Therapeutics Inc

AMRXAmneal Pharmaceuticals Inc

DFTXDefinium Therapeutics Inc

AMRXAmneal Pharmaceuticals Inc

Market cap

$6.25B

P/E (TTM)

40.80x

Forward P/E (NTM)

19.08x

Forward P/S (NTM)

1.89x

Rev growth (TTM)

9.3%

YTD performance

54.6%

52W performance

96.3%

FCF yield

-0.2%

DFTXDefinium Therapeutics Inc

Market cap

$4.28B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

152.1%

52W performance

191.1%

FCF yield

-3.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

AMRX

DFTX

Detailed metrics comparison

AMRX

Amneal Pharmaceuticals Inc

DFTX

Definium Therapeutics Inc

Market Cap

AMRX$6.25B

DFTX$4.28B

Enterprise Value

AMRX$8.85B

DFTX$3.67B

Price

AMRX$19.57

DFTX$34.38

P/E Ratio

AMRX40.80x

DFTXN/A

P/S Ratio

AMRX2.00x

DFTX0.00x

EV/Sales

AMRX2.84x

DFTX0.00x

EV/EBITDA

AMRX13.14x

DFTX0.00x

P/B Ratio

AMRX192.54x

DFTX5.40x

P/FCF Ratio

AMRXN/A

DFTXN/A

EV/FCF

AMRX-719.11x

DFTX-21.83x

PEG Ratio

AMRX1.98x

DFTXN/A

Forward P/E (NTM)

AMRX19.08x

DFTXN/A

Forward P/S (NTM)

AMRX1.89x

DFTXN/A

Revenue (TTM)

AMRX$3.12B

DFTX$0

Revenue Growth (YoY)

AMRX9.3%

DFTXN/A

Forward Rev Growth

AMRX9.0%

DFTX717.7%

Gross Margin (TTM)

AMRX39.3%

DFTX0.0%

Operating Margin (TTM)

AMRX14.6%

DFTX0.0%

EBITDA Margin (TTM)

AMRX21.6%

DFTX0.0%

Net Margin (TTM)

AMRX5.0%

DFTX0.0%

FCF Margin (TTM)

AMRX-0.4%

DFTXN/A

Net Income (TTM)

AMRX$157M

DFTX$-354M

FCF (TTM)

AMRX$-12M

DFTX$-168M

EPS (TTM)

AMRX$0.48

DFTX-$3.20

ROE (TTM)

AMRX174.6%

DFTX-8523.0%

ROA (TTM)

AMRX4.3%

DFTX-6458.0%

ROIC (TTM)

AMRX2.1%

DFTX-7781.0%

Cash

AMRX$128M

DFTX$655M

Debt

AMRX$2.73B

DFTX$36M

Net Cash/Debt

AMRX$-2.60B

DFTX$619M

Current Ratio (TTM)

AMRX2.20x

DFTX6.95x

Quick Ratio (TTM)

AMRX1.38x

DFTX6.89x

Debt/Equity (TTM)

AMRX82.62x

DFTX0.04x

Debt/Assets (TTM)

AMRX0.0%

DFTX0.0%

Interest Coverage (TTM)

AMRXN/A

DFTXN/A

Net Debt/EBITDA (TTM)

AMRX0.00x

DFTX0.00x

Beta

AMRX1.22

DFTX2.23

52W Performance

AMRX96.3%

DFTX191.1%

YTD Performance

AMRX54.6%

DFTX152.1%

% from 52W High

AMRX-7.6%

DFTX-30.8%

% from 52W Low

AMRX104.7%

DFTX228.5%

Asset Turnover (TTM)

AMRX0.85x

DFTX0.00x

FCF Yield (TTM)

AMRX-0.2%

DFTX-3.9%

Earnings Yield (TTM)

AMRX2.5%

DFTX-8.3%

Dividend Yield (TTM)

AMRXN/A

DFTXN/A

Rule of 40

AMRX8.9

DFTX0.0

EV/GP/RG

AMRX1.16

DFTXN/A

Ticker research

View AMRX research View DFTX research

Metric	AMRX Amneal Pharmaceuticals Inc	DFTX Definium Therapeutics Inc
Market & Valuation
Market Cap	$6.25B	$4.28B
Enterprise Value	$8.85B	$3.67B
Price	$19.57	$34.38
P/E Ratio	40.80x	N/A
P/S Ratio	2.00x	0.00x
EV/Sales	2.84x	0.00x
EV/EBITDA	13.14x	0.00x
P/B Ratio	192.54x	5.40x
P/FCF Ratio	N/A	N/A
EV/FCF	-719.11x	-21.83x
PEG Ratio	1.98x	N/A
Forward P/E (NTM)	19.08x	N/A
Forward P/S (NTM)	1.89x	N/A
Revenue & Growth
Revenue (TTM)	$3.12B	$0
Revenue Growth (YoY)	9.3%	N/A
Forward Rev Growth	9.0%	717.7%
Profitability
Gross Margin (TTM)	39.3%	0.0%
Operating Margin (TTM)	14.6%	0.0%
EBITDA Margin (TTM)	21.6%	0.0%
Net Margin (TTM)	5.0%	0.0%
FCF Margin (TTM)	-0.4%	N/A
Net Income (TTM)	$157M	$-354M
FCF (TTM)	$-12M	$-168M
EPS (TTM)	$0.48	-$3.20
ROE (TTM)	174.6%	-8523.0%
ROA (TTM)	4.3%	-6458.0%
ROIC (TTM)	2.1%	-7781.0%
Financial Health
Cash	$128M	$655M
Debt	$2.73B	$36M
Net Cash/Debt	$-2.60B	$619M
Current Ratio (TTM)	2.20x	6.95x
Quick Ratio (TTM)	1.38x	6.89x
Debt/Equity (TTM)	82.62x	0.04x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.22	2.23
52W Performance	96.3%	191.1%
YTD Performance	54.6%	152.1%
% from 52W High	-7.6%	-30.8%
% from 52W Low	104.7%	228.5%
Efficiency & Yields
Asset Turnover (TTM)	0.85x	0.00x
FCF Yield (TTM)	-0.2%	-3.9%
Earnings Yield (TTM)	2.5%	-8.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	8.9	0.0
EV/GP/RG	1.16	N/A
Ticker research	View AMRX research	View DFTX research

Valuation

P/E Ratio

AMRX

40.80x

P/S Ratio

DFTX

0.00x

AMRX

2.00x

EV/FCF

AMRX

-719.11x

DFTX

-21.83x

Growth & revenue

Revenue Growth TTM

AMRX

9.3%

Forward Revenue Growth

DFTX

717.7%

AMRX

9.0%

Profitability & performance

Gross Margin

AMRX

39.3%

DFTX

0.0%

ROE

AMRX

174.6%

DFTX

-8523.0%

FCF Yield %

AMRX

-0.2%

DFTX

-3.9%

52-Week Performance

DFTX

191.1%

AMRX

96.3%

Detailed metrics comparison

AMRX

Amneal Pharmaceuticals Inc

DFTX

Definium Therapeutics Inc

Market Cap

AMRX$6.25B

DFTX$4.28B

Enterprise Value

AMRX$8.85B

DFTX$3.67B

Price

AMRX$19.57

DFTX$34.38

P/E Ratio

AMRX40.80x

DFTXN/A

P/S Ratio

AMRX2.00x

DFTX0.00x

EV/Sales

AMRX2.84x

DFTX0.00x

EV/EBITDA

AMRX13.14x

DFTX0.00x

P/B Ratio

AMRX192.54x

DFTX5.40x

P/FCF Ratio

AMRXN/A

DFTXN/A

EV/FCF

AMRX-719.11x

DFTX-21.83x

PEG Ratio

AMRX1.98x

DFTXN/A

Forward P/E (NTM)

AMRX19.08x

DFTXN/A

Forward P/S (NTM)

AMRX1.89x

DFTXN/A

Revenue (TTM)

AMRX$3.12B

DFTX$0

Revenue Growth (YoY)

AMRX9.3%

DFTXN/A

Forward Rev Growth

AMRX9.0%

DFTX717.7%

Gross Margin (TTM)

AMRX39.3%

DFTX0.0%

Operating Margin (TTM)

AMRX14.6%

DFTX0.0%

EBITDA Margin (TTM)

AMRX21.6%

DFTX0.0%

Net Margin (TTM)

AMRX5.0%

DFTX0.0%

FCF Margin (TTM)

AMRX-0.4%

DFTXN/A

Net Income (TTM)

AMRX$157M

DFTX$-354M

FCF (TTM)

AMRX$-12M

DFTX$-168M

EPS (TTM)

AMRX$0.48

DFTX-$3.20

ROE (TTM)

AMRX174.6%

DFTX-8523.0%

ROA (TTM)

AMRX4.3%

DFTX-6458.0%

ROIC (TTM)

AMRX2.1%

DFTX-7781.0%

Cash

AMRX$128M

DFTX$655M

Debt

AMRX$2.73B

DFTX$36M

Net Cash/Debt

AMRX$-2.60B

DFTX$619M

Current Ratio (TTM)

AMRX2.20x

DFTX6.95x

Quick Ratio (TTM)

AMRX1.38x

DFTX6.89x

Debt/Equity (TTM)

AMRX82.62x

DFTX0.04x

Debt/Assets (TTM)

AMRX0.0%

DFTX0.0%

Interest Coverage (TTM)

AMRXN/A

DFTXN/A

Net Debt/EBITDA (TTM)

AMRX0.00x

DFTX0.00x

Beta

AMRX1.22

DFTX2.23

52W Performance

AMRX96.3%

DFTX191.1%

YTD Performance

AMRX54.6%

DFTX152.1%

% from 52W High

AMRX-7.6%

DFTX-30.8%

% from 52W Low

AMRX104.7%

DFTX228.5%

Asset Turnover (TTM)

AMRX0.85x

DFTX0.00x

FCF Yield (TTM)

AMRX-0.2%

DFTX-3.9%

Earnings Yield (TTM)

AMRX2.5%

DFTX-8.3%

Dividend Yield (TTM)

AMRXN/A

DFTXN/A

Rule of 40

AMRX8.9

DFTX0.0

EV/GP/RG

AMRX1.16

DFTXN/A

Ticker research

View AMRX research View DFTX research

Metric	AMRX Amneal Pharmaceuticals Inc	DFTX Definium Therapeutics Inc
Market & Valuation
Market Cap	$6.25B	$4.28B
Enterprise Value	$8.85B	$3.67B
Price	$19.57	$34.38
P/E Ratio	40.80x	N/A
P/S Ratio	2.00x	0.00x
EV/Sales	2.84x	0.00x
EV/EBITDA	13.14x	0.00x
P/B Ratio	192.54x	5.40x
P/FCF Ratio	N/A	N/A
EV/FCF	-719.11x	-21.83x
PEG Ratio	1.98x	N/A
Forward P/E (NTM)	19.08x	N/A
Forward P/S (NTM)	1.89x	N/A
Revenue & Growth
Revenue (TTM)	$3.12B	$0
Revenue Growth (YoY)	9.3%	N/A
Forward Rev Growth	9.0%	717.7%
Profitability
Gross Margin (TTM)	39.3%	0.0%
Operating Margin (TTM)	14.6%	0.0%
EBITDA Margin (TTM)	21.6%	0.0%
Net Margin (TTM)	5.0%	0.0%
FCF Margin (TTM)	-0.4%	N/A
Net Income (TTM)	$157M	$-354M
FCF (TTM)	$-12M	$-168M
EPS (TTM)	$0.48	-$3.20
ROE (TTM)	174.6%	-8523.0%
ROA (TTM)	4.3%	-6458.0%
ROIC (TTM)	2.1%	-7781.0%
Financial Health
Cash	$128M	$655M
Debt	$2.73B	$36M
Net Cash/Debt	$-2.60B	$619M
Current Ratio (TTM)	2.20x	6.95x
Quick Ratio (TTM)	1.38x	6.89x
Debt/Equity (TTM)	82.62x	0.04x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.22	2.23
52W Performance	96.3%	191.1%
YTD Performance	54.6%	152.1%
% from 52W High	-7.6%	-30.8%
% from 52W Low	104.7%	228.5%
Efficiency & Yields
Asset Turnover (TTM)	0.85x	0.00x
FCF Yield (TTM)	-0.2%	-3.9%
Earnings Yield (TTM)	2.5%	-8.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	8.9	0.0
EV/GP/RG	1.16	N/A
Ticker research	View AMRX research	View DFTX research